These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 32448163)
1. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163 [TBL] [Abstract][Full Text] [Related]
2. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer. Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699 [TBL] [Abstract][Full Text] [Related]
3. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis. Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377 [TBL] [Abstract][Full Text] [Related]
4. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling. Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535 [TBL] [Abstract][Full Text] [Related]
5. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts. Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
7. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling. Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313 [TBL] [Abstract][Full Text] [Related]
8. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H Du SF; Wang XL; Ye CL; He ZJ; Li DX; Du BR; Liu YJ; Zhu XY Acta Physiol (Oxf); 2019 Feb; 225(2):e13177. PubMed ID: 30136377 [TBL] [Abstract][Full Text] [Related]
9. The antifibrotic effect of pheretima protein is mediated by the TGF-β1/Smad2/3 pathway and attenuates inflammation in bleomycin-induced idiopathic pulmonary fibrosis. Li S; Yang Q; Chen F; Tian L; Huo J; Meng Y; Tang Q; Wang W J Ethnopharmacol; 2022 Mar; 286():114901. PubMed ID: 34890730 [TBL] [Abstract][Full Text] [Related]
10. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway. Yin JZ; Li ZQ; Zhang XD; Wan ZJ; Qin HR; Yao LH; Li BL; Gao F; Yang YY Eur J Pharmacol; 2024 Feb; 964():176293. PubMed ID: 38158113 [TBL] [Abstract][Full Text] [Related]
11. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
12. Respiratory exposure to nano-TiO Zhou Y; Ji J; Ji L; Wang L; Hong F J Biomed Mater Res A; 2019 Nov; 107(11):2567-2575. PubMed ID: 31356723 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2. Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840 [TBL] [Abstract][Full Text] [Related]
15. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis. Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194 [TBL] [Abstract][Full Text] [Related]
16. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992 [TBL] [Abstract][Full Text] [Related]
17. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21. Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B Nephron; 2022; 146(1):110-120. PubMed ID: 34724669 [TBL] [Abstract][Full Text] [Related]
18. Cdc42-interacting protein 4 silencing relieves pulmonary fibrosis in STZ-induced diabetic mice via the Wnt/GSK-3β/β-catenin pathway. Zhang X; Liu Y; Shao R; Li W Exp Cell Res; 2017 Oct; 359(1):284-290. PubMed ID: 28720386 [TBL] [Abstract][Full Text] [Related]
19. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway. Ying H; Fang M; Hang QQ; Chen Y; Qian X; Chen M J Cell Mol Med; 2021 Sep; 25(18):8662-8675. PubMed ID: 34327818 [TBL] [Abstract][Full Text] [Related]
20. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]